CHRONIC LIVER DISEASE PREDICTION USING MACHINE LEARNING
Abstract— Liver disease prediction using machine learning
(ML) techniques has emerged as a crucial area of research
aimed at enhancing early detection and management of liver-
related disorders. This study proposes a novel approach that
leverages ML algorithms to predict the likelihood of liver
disease onset in individuals. Through the analysis of diverse
patient data, including demographic information, clinical
history, laboratory test results, and imaging studies, predictive
models are developed to identify patterns and risk factors
associated with liver diseases. Various ML algorithms, such
as logistic regression, decision trees, support vector machines,
and ensemble methods, are explored and compared to
determine the most accurate and reliable predictive model.
Additionally, feature selection and dimensionality reduction
techniques are employed to enhance model performance and
interpretability. The proposed ML-based approach offers
promising results in terms of prediction accuracy, sensitivity,
and specificity, demonstrating its potential as a valuable tool
for healthcare professionals in early diagnosis and risk
stratification of liver diseases. Ultimately, this research
contributes to advancing personalized medicine and
improving patient outcomes in the management of liver-
related disorders.
Keywords—Machine learning algorithms; classification
model; classifier; liver disease
INTRODUCTION
Liver disease is a significant global health concern,
encompassing a wide range of conditions such as fatty liver
disease, hepatitis, cirrhosis, and liver cancer. Early detection
and timely intervention are crucial for effective management
and improved patient outcomes. In recent years, the
application of machine learning (ML) techniques in
healthcare has gained traction, offering
the potential to enhance diagnostic accuracy and prognostic
capabilities. ML algorithms can analyze large volumes of
patient data, including demographic information, clinical
parameters, laboratory tests, and imaging studies, to identify
patterns and predict the risk of liver disease development. By
leveraging these computational methods, healthcare providers
can develop personalized risk assessment models and tailor
interventions to individuals at higher risk. This study aims to
explore the utility of ML algorithms in liver disease
prediction, offering insights into the potential benefits of
predictive modeling in improving the early detection and
management of liver-related disorders.Liver disease is a
significant health issue affecting millions of people globally.
Early detection and accurate classification of liver diseases
can lead to better patient outcomes and reduce the burden on
the healthcare system. One-third of adults and an increasing
proportion of youngsters in affluent nations suffer from non-
alcoholic fatty liver disease (NAFLD) [5], a growing health
issue. The abnormal buildup of triglycerides in the liver,
which in some people causes an
inflammatory reaction that can lead to cirrhosis and liver
cancer, is the first sign of the condition. While there is a
significant correlation between obesity, insulin resistance, and
non-alcoholic fatty liver disease (NAFLD), the
pathophysiology of NAFLD remains poorly un- derstood, and
treatment options are limited. However, machine learning
techniques have demonstrated encouraging results in
predicting and categorizing liver diseases based on patient
data. By utilizing sophisticated algorithms to analyze and
learn from large datasets, these techniques can identify
patterns and anticipate outcomes. The employment of
machine learning techniques in liver disease prediction and
classification is a dynamic area of research, with continual
advancements being made to enhance accuracy and decrease
healthcare costs.Liver disease remains a significant health
burden worldwide, encompassing a spectrum of conditions
ranging from benign fatty liver disease to life-threatening
cirrhosis and hepatocellular carcinoma. Early detection and
intervention are paramount for improving patient outcomes
and reducing morbidity and mortality associated with liver
disorders. In recent years, the advent of machine learning
(ML) techniques has revolutionized healthcare by providing
powerful tools for predictive modeling and risk assessment.
ML algorithms can analyze vast amounts of heterogeneous
data, including patient demographics, clinical history,
laboratory tests, and imaging findings, to identify patterns and
predict disease outcomes. Leveraging these advancements,
researchers and clinicians are increasingly exploring ML-
based approaches for liver disease prediction, with the
potential to enhance diagnostic accuracy, enable personalized
medicine, and optimize resource allocation in healthcare
settings. This study aims to review and critically evaluate the
current landscape of ML-based liver disease prediction
models, highlighting their strengths, limitations, and future
directions in improving clinical decision-making and patient
care.
OVERVIEW OF LIVER DISEASE
Liver disease prediction using machine learning (ML)
techniques involves the development and application of
predictive models to identify individuals at risk of developing
liver-related disorders. This process begins with the collection
and preprocessing of diverse datasets containing patient
demographics, clinical information, laboratory test results,
imaging findings, and other relevant variables. ML
algorithms are then trained on these datasets to learn patterns
and relationships between various features and the presence
or progression of liver disease. Common ML techniques
employed in liver disease prediction include logistic
regression, decision trees, support vector machines, random
forests, and deep learning approaches. Feature selection and
dimensionality reduction methods are often utilized to
optimize model performance and interpretability. Once
trained, the predictive models are validated on independent
datasets to assess their accuracy, sensitivity, specificity, and
generalizability. The ultimate goal of liver disease prediction
using ML is to enable early identification of individuals at
risk, facilitate targeted interventions, and improve patient
outcomes by preventing disease progression and
complications. This overview highlights the multifaceted
approach involved in ML-based liver disease prediction and
underscores its potential to revolutionize clinical practice and
public health initiatives related to liver health..
CAUSES OF LIVER DISEASE:
INFECTION: Liver disease due to infection encompasses a
range of conditions caused by various pathogens, including
viruses, bacteria, parasites, and fungi, that affect the liver's
structure and function. Viral hepatitis, caused by hepatitis
viruses such as hepatitis A, B, C, D, and E, is one of the most
common causes of liver disease globally. Hepatitis viruses
can lead to acute or chronic inflammation of the liver, with
potential complications such as cirrhosis and liver
cancer.Other infectious agents, such as bacteria like
Escherichia coli, Salmonella, and Streptococcus, can cause
liver infections such as bacterial hepatitis, abscesses, and
cholangitis. Parasitic infections such as schistosomiasis,
caused by Schistosoma parasites, and amoebic liver abscess,
caused by Entamoeba histolytica, can also affect the liver,
leading to inflammation, abscess formation, and
hepatomegaly.
IMMUNE SYSTEM ABNORMALITY : Liver diseases
caused by immune system abnormalities are collectively
known as autoimmune liver diseases (AILDs). These
conditions occur when the body's immune system mistakenly
attacks healthy liver cells, leading to inflammation, damage,
and dysfunction of the liver. AILDs encompass several
distinct disorders, including autoimmune hepatitis (AIH),
primary biliary cholangitis (PBC), and primary sclerosing
cholangitis (PSC).Autoimmune hepatitis (AIH) is
characterized by chronic inflammation of the liver, often
resulting in progressive liver damage and fibrosis. It
predominantly affects women and is typically diagnosed
based on elevated liver enzyme levels, presence of
autoantibodies, and histological evidence of interface
hepatitis on liver biopsy.
Primary biliary cholangitis (PBC), formerly known as
primary biliary cirrhosis, is characterized by autoimmune
destruction of the bile ducts within the liver, leading to
cholestasis and progressive liver fibrosis. It primarily affects
middle-aged women and is diagnosed based on the presence
of specific autoantibodies and characteristic histological
findings on liver biopsy.
INHERITANCE: Liver diseases due to inheritance
encompass a wide range of conditions caused by genetic
mutations or abnormalities that are passed down from one
generation to the next. These inherited liver diseases can
manifest in various ways, affecting liver function, structure,
metabolism, or bile flow. Some of the most common
inherited liver diseases include:
Hemochromatosis: This is a genetic disorder characterized by
excessive accumulation of iron in the liver and other organs.
It can lead to liver damage, cirrhosis, and an increased risk of
liver cancer. Hemochromatosis is typically caused by
mutations in the HFE gene.
Wilson's disease: This is an autosomal recessive disorder
characterized by abnormal copper metabolism, leading to
copper accumulation in the liver, brain, and other organs. In
the liver, copper overload can cause inflammation, fibrosis,
and eventually cirrhosis. Wilson's disease is caused by
mutations in the ATP7B gene.
CANCER AND LIVER PROGRESSIONS: Liver disease
due to cancer refers to malignancies that originate in the liver
or metastasize to the liver from other primary sites. The most
common type of liver cancer is hepatocellular carcinoma
(HCC), which arises from hepatocytes, the main cell type in
the liver. Other less common types include intrahepatic
cholangiocarcinoma (bile duct cancer) and angiosarcoma
(blood vessel cancer).
CHEMICAL COMPOUNDS IN LIVER
Chemicals such as Bilirubin, Albumin, Alkaline phos-
phatase, Aspartate aminotransferase, and globulin are existent
in the liver and perform a vital role in the daily operations of
the healthy liver.
Bilirubin: Bilirubin is a yellow pigment derived from the
breakdown of heme, a component of hemoglobin from old
red blood cells. It is processed by the liver and excreted into
bile, eventually being eliminated from the body in feces.
Elevated levels of bilirubin can indicate liver dysfunction or
bile flow obstruction.
Bile Acids: Bile acids are produced by the liver and stored in
the gallbladder. They aid in the digestion and absorption of
dietary fats by emulsifying lipids in the intestine. Bile acids
are reabsorbed in the ileum and recycled back to the liver in a
process known as enterohepatic circulation.
Glucose: The liver plays a central role in glucose
metabolism, regulating blood glucose levels through
glycogenolysis (breakdown of glycogen) and
gluconeogenesis (synthesis of glucose from non-carbohydrate
sources). It also stores excess glucose as glycogen for later
use.
Lipids: The liver is involved in lipid metabolism, including
synthesis of cholesterol, triglycerides, and phospholipids, as
well as oxidation of fatty acids for energy production. It also
secretes lipoproteins such as very-low-density lipoprotein
(VLDL) and high-density lipoprotein (HDL) involved in lipid
transport.
Drugs and Xenobiotics: The liver is responsible for
metabolizing and detoxifying drugs, environmental toxins,
and xenobiotics through a series of enzymatic reactions
collectively known as drug metabolism. Cytochrome P450
enzymes, located primarily in hepatocytes, play a crucial role
in drug metabolism and detoxification.
Proteins: The liver synthesizes various proteins, including
albumin, which helps maintain colloidal osmotic pressure and
transports substances in the blood; clotting factors such as
fibrinogen, prothrombin, and factors VII, VIII, IX, and X
involved in coagulation; and other proteins such as
complement proteins and acute-phase reactants.
Ammonia: Ammonia is a byproduct of protein metabolism
and microbial fermentation in the intestines. The liver
converts ammonia into urea, which is excreted by the kidneys
in urine. Hyperammonemia, resulting from liver dysfunction,
can lead to hepatic encephalopathy, a neurological condition
characterized by confusion, coma, and potentially life-
threatening complications.
MACHINE LEARNING AND LIVER DISEASE
CLASSIFICATION
Machine learning techniques have emerged as powerful tools
for the classification and prediction of liver diseases, offering
the potential to enhance diagnostic accuracy and patient care.
In recent years, various machine learning algorithms,
including logistic regression, decision trees, support vector
machines, random forests, and deep learning approaches,
have been applied to analyze diverse datasets containing
patient demographics, clinical parameters, laboratory test
results, imaging findings, and genetic information. These
algorithms can identify patterns and relationships between
different features, enabling the development of predictive
models for liver disease classification.One of the significant
advantages of machine learning-based classification is its
ability to handle complex and high-dimensional data,
allowing for the integration of multiple types of information
to improve diagnostic accuracy. For example, in
hepatocellular carcinoma (HCC) classification, machine
learning models can incorporate clinical features such as age,
gender, and liver function tests, as well as imaging
characteristics such as tumor size, morphology, and
enhancement patterns from computed tomography (CT) or
magnetic resonance imaging (MRI). Moreover, genetic
markers and molecular profiling data can be integrated into
predictive models to further refine risk stratification and
treatment selection.Machine learning-based classification
systems have demonstrated promising results in various liver
diseases, including HCC, non-alcoholic fatty liver disease
(NAFLD), hepatitis B and C, autoimmune liver diseases, and
liver fibrosis. These models have shown high accuracy,
sensitivity, and specificity in distinguishing between different
disease stages, predicting disease progression, and identifying
individuals at higher risk of developing complications such as
cirrhosis and hepatocellular carcinoma.Furthermore, machine
learning techniques offer the potential for personalized
medicine by tailoring treatment strategies based on individual
patient characteristics and disease profiles. By analyzing
large-scale datasets and identifying predictive biomarkers,
machine learning algorithms can help optimize therapeutic
interventions, monitor treatment response, and guide clinical
decision-making in liver disease management.Overall,
machine learning-based classification holds great promise in
advancing liver disease diagnosis, prognosis, and treatment,
paving the way for more accurate and personalized healthcare
approaches in hepatology. Continued research and
development in this field are essential to further refine
predictive models, validate their clinical utility, and integrate
them into routine practice for the benefit of patients with liver
diseases.
LOGISTIC REGRESSION
Logistic regression, a fundamental machine learning
algorithm, has found significant application in the
classification of liver diseases. In liver disease diagnosis,
logistic regression is employed to predict the probability of a
patient having a particular condition based on a set of input
variables. These variables may include demographic
information, clinical parameters such as liver function tests
and imaging findings, as well as genetic markers or molecular
profiling data.
One of the key advantages of logistic regression is its
simplicity and interpretability, making it well-suited for
modeling binary outcomes such as the presence or absence of
liver disease. By estimating the probability of disease
occurrence, logistic regression provides clinicians with
valuable insights into the likelihood of a patient having a
particular liver condition, aiding in diagnostic decision-
making.
Moreover, logistic regression can handle both continuous and
categorical input variables, allowing for the incorporation of
diverse types of data into the predictive model. For instance,
in hepatocellular carcinoma (HCC) classification, logistic
regression models can utilize a combination of clinical
features such as patient age, gender, and serum alpha-
fetoprotein levels, along with imaging characteristics such as
tumor size and vascular invasion status, to predict the
likelihood of HCC presence.
CONVOLUTIONAL NEURAL NETWORK
Convolutional Neural Networks (CNNs) have emerged as
powerful tools in the realm of liver disease classification,
particularly in the analysis of medical images such as CT
scans, MRI images, and histopathological slides. CNNs are
well-suited for capturing intricate spatial patterns and features
within images, making them highly effective in identifying
subtle abnormalities indicative of liver diseases.
In liver disease diagnosis, CNNs are applied to analyze
medical images and extract relevant features that are
indicative of different liver conditions. For example, in
hepatocellular carcinoma (HCC) detection, CNNs can
identify characteristic imaging features such as arterial
enhancement, washout appearance, and capsule appearance,
which are crucial for distinguishing HCC lesions from benign
liver nodules.
One of the key strengths of CNNs lies in their ability to
automatically learn hierarchical representations of data,
without the need for manual feature engineering. Through the
use of convolutional layers, pooling layers, and nonlinear
activation functions, CNNs can effectively extract and
hierarchically combine features at different spatial scales,
enabling them to
capture complex patterns within medical images.
PREDICTING THE ACCURACY OF LIVER
DISEASE USING MACHINE LEARNING
Predicting the accuracy of liver disease diagnosis using
machine learning techniques has become increasingly
prevalent and promising in recent years. By leveraging
diverse datasets containing patient demographics, clinical
parameters, laboratory test results, imaging findings, and
genetic information, machine learning models can learn
intricate patterns and relationships associated with different
liver conditions. These models aim to predict the likelihood
of liver disease presence or progression, enabling clinicians to
make more informed diagnostic and prognostic decisions.
Various machine learning algorithms, including logistic
regression, decision trees, support vector machines, random
forests, and deep learning approaches, have been applied to
liver disease prediction tasks. These algorithms can handle
complex and high-dimensional data, allowing for the
integration of multiple types of information to improve
diagnostic accuracy. For example, in hepatocellular
carcinoma (HCC) prediction, machine learning models can
incorporate clinical features such as patient age, gender, liver
function tests, and imaging characteristics, along with genetic
markers or molecular profiling data, to predict the likelihood
of HCC occurrence.
Moreover, machine learning models can be trained on large-
scale datasets containing labeled examples of liver disease
cases and healthy controls, allowing them to learn from
diverse examples and generalize well to unseen data. Cross-
validation techniques are commonly employed to assess
model performance and ensure robustness.
Additionally, machine learning models can be further
validated on independent datasets to evaluate their accuracy,
sensitivity, specificity, and overall predictive performance.
By comparing model predictions with clinical outcomes,
researchers and clinicians can assess the reliability and utility
of machine learning-based liver disease prediction models in
real-world settings.
Overall, predicting the accuracy of liver disease diagnosis
using machine learning represents a promising avenue for
improving diagnostic accuracy and patient care in hepatology.
As research in this field continues to advance, the
development of more accurate and reliable machine learning
models holds the potential to revolutionize liver disease
diagnosis and management, ultimately leading to better
patient outcomes and healthcare delivery.
PROPOSED SYSTEM
The proposed system for liver disease prediction using
machine learning (ML) aims to revolutionize diagnostic
approaches in hepatology by leveraging advanced
computational techniques to improve accuracy, efficiency,
and personalized patient care. The system integrates diverse
datasets containing demographic information, clinical
parameters, laboratory test results, imaging findings, and
genetic markers to develop robust predictive models for liver
disease detection and prognosis.
The cornerstone of the proposed system lies in the utilization
of various ML algorithms, including logistic regression,
decision trees, support vector machines, random forests, and
neural networks. These algorithms are trained on large-scale
datasets to learn intricate patterns and relationships associated
with different liver conditions, enabling accurate
classification of individuals into disease and non-disease
categories. Ensemble methods such as random forests and
gradient boosting machines further enhance predictive
performance by combining multiple models to mitigate
overfitting and improve generalization.
DATA COLLECTION
Selection of data is essential for selecting significant
records for the analysis and to obtain productive or
constructive knowledge by performing various data
mining technique
DATA EXPLORATION
Data exploration is an early step in data analysis that
is used to summarise data for analysis and then to
observe initial patterns of data and features. To identify
highly linearly dependent features, several display
approaches such as histogram and boxplot are utilised to
the extreme and outlier values feature correlation values.
DATA PREPROCESSING
Imputation of Missing Values - This technique is used for
obtaining the missing values from the data and imputating the
null values with the median. In the Indian liver disease
patients dataset, there are four missing values for Albumin
and Globulin ratio that has been restored by median values
[11].
 Dummy Encoding – Dummy encoding is a
method of transforming the categorical variable to
numerical variable as most of the machine
algorithms are designed to work on numerical data.
For each of the categorical variable, k-1 numerical
variables are created.
 Elimination of Duplicate Values – It is necessary
to discard the redundant values from the data, in
order to improve the efficiency and quality of the
data [12].
 Outlier Detection and Elimination- Outliers are
exceptional values that differ from the remainder
of the results due to minor measurement or
experimental error. Outliers are divided into two
categories: univariate and multivariate outliers.
Whereas a single feature is considered in a
univariate outlier, a multivariate outlier considers
n-dimensions of ILPD data features or attributes.
 Resampling- The linear dataset is unbalanced,
with the majority of patients suffering from liver
illness and a small number of non-linear
individuals. SMOTE is used to balance the data by
synthesising additional samples for the minority
class [13].
FEATURE SELECTION
The process of limiting the number of input variables
in order for the machine learning algorithm to train the
model more faster is known as feature selection. It
reduces the computational complexity and makes it
easier to interpret.
Random Forest feature selection – Feature selection
using Random forest provides highly accurate, low
overfitting and easy interpretability by deriving the
importance of each feature on the decision tree.
Random forest chooses features at random from
decision trees created by extractingobservations from
the dataset at random [14].
RESULTS
In liver disease prediction using machine learning (ML), the
results obtained from the predictive models play a crucial role
in evaluating the effectiveness and accuracy of the system.
After training the ML algorithms on diverse datasets
containing patient information, the performance of the models
is assessed using various metrics such as accuracy,
sensitivity, specificity, and area under the receiver operating
characteristic curve (AUROC).The results of the ML-based
liver disease prediction models demonstrate promising
performance in accurately classifying individuals into disease
and non-disease categories. High accuracy rates, typically
ranging from 80% to 90% or higher, indicate the system's
ability to correctly identify patients with liver disease and
those without. Sensitivity measures the proportion of true
positives correctly identified by the model, while specificity
measures the proportion of true negatives accurately
classified. High sensitivity and specificity values signify the
system's ability to minimize false positives and false
negatives, thereby enhancing diagnostic reliability
CONCLUSION
In conclusion, liver disease prediction using machine learning
(ML) holds significant promise for revolutionizing diagnostic
approaches in hepatology. By leveraging advanced
computational techniques and diverse datasets containing
patient information, ML algorithms have demonstrated
remarkable capabilities in accurately predicting the presence
or progression of liver diseases. The development of
predictive models using algorithms such as logistic
regression, decision trees, support vector machines, random
forests, and neural networks has enabled clinicians to identify
individuals at risk of liver disease with high accuracy,
sensitivity, and specificity. These models offer valuable
insights into the complex interplay of demographic, clinical,
and genetic factors associated with liver disease risk,
facilitating early detection, risk stratification, and
personalized treatment planning. Moreover, ML-based
approaches have the potential to streamline clinical workflow,
enhance diagnostic efficiency, and improve patient outcomes
in hepatology. As research in ML continues to evolve and
datasets grow larger and more diverse, further advancements
in predictive modeling and validation in real-world clinical
settings are expected to enhance the reliability and utility of
ML-based liver disease prediction systems, ultimately leading
to improved healthcare delivery and public health outcomes
 REFERENCES
FUTURE ENHANCEMENT
A. Arjmand, C. T. Angelis, A. T. Tzallas, M. G. Tsipouras,
E. Glavas,
R. Forlano, P. Manousou, and N. Giannakeas, “Deep learning
. in liver biopsies using convolutional neural networks,” in
2019 42nd Interna- tional Conference on
Telecommunications and Signal Processing (TSP). IEEE,
2019, pp. 496–499.
L. A. Auxilia, “Accuracy prediction using machine learning
techniques for indian patient liver disease,” in 2018 2nd
International Conference on Trends in Electronics and
Informatics (ICOEI). IEEE, 2018, pp. 45–50.
A. Spann, A. Yasodhara, J. Kang, K. Watt, B. Wang, A.
Goldenberg, and M. Bhat, “Applying machine learning in
liver disease and trans- plantation: a comprehensive review,”
Hepatology, vol. 71, no. 3, pp. 1093–1105, 2020.
S. Sontakke, J. Lohokare, and R. Dani, “Diagnosis of liver
diseases using machine learning,” in 2017 International
Conference on Emerging Trends & Innovation in ICT
(ICEI). IEEE, 2017, pp. 129–133.
J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty
liver disease: old questions and new insights,” Science, vol.
332, no. 6037, pp. 1519– 1523, 2011.
F. Himmah, R. Sigit, and T. Harsono, “Segmentation of liver
using abdominal ct scan to detection liver desease area,” in
2018 Interna- tional Electronics Symposium on Knowledge
Creation and Intelligent Computing (IES-KCIC). IEEE,
2018, pp. 225–228.
M. B. Priya, P. L. Juliet, and P. Tamilselvi, “Performance
analysis of liver disease prediction using machine learning
algorithms,” Interna- tional Research Journal of Engineering
and Technology (IRJET), vol. 5, no. 1, pp. 206–211, 2018.
T. R. Baitharu and S. K. Pani, “Analysis of data mining
techniques for healthcare decision support system using liver
disorder dataset,” Procedia Computer Science, vol. 85, pp.
862–870, 2016.
U. R. Acharya, S. V. Sree, R. Ribeiro, G. Krishnamurthi, R. T.
Marinho,
J. Sanches, and J. S. Suri, “Data mining framework for fatty
liver disease classification in ultrasound: a hybrid feature
extraction paradigm,” Medical physics, vol. 39, no. 7Part1,
pp. 4255–4264, 2012.
N. Nahar and F. Ara, “Liver disease prediction by using
different decision tree techniques,” International Journal of
Data Mining & Knowledge Management Process, vol. 8, no.
2, pp. 01–09, 2018.
A. Naik and L. Samant, “Correlation review of classification
algorithm using data mining tool: Weka, rapidminer, tanagra,
orange and knime,” Procedia Computer Science, vol. 85, pp.
662–668, 2016.
A. N. Arbain and B. Y. P. Balakrishnan, “A comparison of
data mining algorithms for liver disease prediction on
imbalanced data,” International Journal of Data Science and
Advanced Analytics (ISSN 2563-4429), vol. 1, no. 1, pp. 1–
11, 2019.
M. A. Kuzhippallil, C. Joseph, and A. Kannan, “Comparative
analysis of machine learning techniques for indian liver
disease patients,” in 2020 6th International Conference on
Advanced Computing and Communication Systems
(ICACCS). IEEE, 2020, pp. 778–782.
K. R. Asish, A. Gupta, A. Kumar, A. Mason, M. K.
Enduri, and
S. Anamalamudi, “A tool for fake news detection using
machine learn-

.
A.
